Cite
Chehrazi-Raffle A, Meza L, Alcantara M, et al. Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma. J Immunother Cancer. 2021;9(3)doi: 10.1136/jitc-2020-002009.
Chehrazi-Raffle, A., Meza, L., Alcantara, M., Dizman, N., Bergerot, P., Salgia, N., Hsu, J., Ruel, N., Salgia, S., Malhotra, J., Karczewska, E., Kortylewski, M., & Pal, S. (2021). Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma. Journal for immunotherapy of cancer, 9(3), . https://doi.org/10.1136/jitc-2020-002009
Chehrazi-Raffle, Alexander, et al. "Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma." Journal for immunotherapy of cancer vol. 9,3 (2021). doi: https://doi.org/10.1136/jitc-2020-002009
Chehrazi-Raffle A, Meza L, Alcantara M, Dizman N, Bergerot P, Salgia N, Hsu J, Ruel N, Salgia S, Malhotra J, Karczewska E, Kortylewski M, Pal S. Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma. J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-002009. PMID: 33688021; PMCID: PMC7944971.
Copy
Download .nbib